MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
479.21%
Quick Ratio
479.21%
Cash Ratio
409.99%
Debt to Asset Ratio
20.87%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Restricted cash
    • Prepaid expenses and other curre...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued lia...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
14,915,519 16,068,048 17,589,978 10,461,971
Restricted cash
723,136 974,799 1,352,975 1,352,975
Prepaid expenses and deposits
NaN 658,750 1,126,724 1,278,589
Prepaid expenses and other current assets
418,053 NaN NaN NaN
Other receivables
1,377,300 1,369,400 1,665,153 1,674,335
Total current assets
17,434,008 19,070,997 21,734,830 14,767,870
Total assets
17,434,008 19,070,997 21,734,830 14,767,870
Deferred revenue
NaN 974,799 1,352,975 1,352,975
Accounts payable and accrued liabilities
1,913,685 1,299,384 1,664,647 2,267,871
Related party payable
1,001,229 NaN 328,315 656,631
Deferred grant income
723,136 NaN NaN NaN
Total current liabilities
3,638,050 2,274,183 3,345,937 4,277,477
Total liabilities
3,638,050 2,274,183 3,345,937 4,277,477
Common stock, 0.001 par value, 30 million shares authorized, 16.7 million shares issued and outstanding as of march 31, 2026 and december 31, 2025 (see note 8)
16,672 16,672 16,672 11,313
Additional paid-in capital
476,139,362 475,960,940 475,849,809 465,958,006
Accumulated deficit
-462,360,076 -459,180,798 -457,477,588 -455,478,926
Total stockholders' equity
13,795,958 16,796,814 18,388,893 10,490,393
Total liabilities and stockholders' equity
17,434,008 19,070,997 21,734,830 14,767,870
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$14,915,519 Other receivables$1,377,300 Restricted cash$723,136 Prepaid expenses andother current assets$418,053 Total current assets$17,434,008 Total assets$17,434,008 Total liabilities andstockholders' equity$17,434,008 Total stockholders'equity$13,795,958 Total liabilities$3,638,050 Accumulated deficit-$462,360,076 Additional paid-in capital$476,139,362 Total currentliabilities$3,638,050 Common stock, 0.001 parvalue, 30 million...$16,672 Accounts payable andaccrued liabilities$1,913,685 Related party payable$1,001,229 Deferred grant income$723,136

Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics, Inc. (MRKR)